Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury

Abhinav Kanwal, Hina L. Nizami, Surekha Mallapudi, Uday Kumar Putcha, G. Krishna Mohan, Sanjay K. Banerjee

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Recently, we reported Na+/glucose co-transporter (SGLT1) expression in mouse and human heart. We speculated that SGLT1 might play an important role in ischemic preconditioning-induced cardioprotection. Therefore, the present study was designed to find the role of SGLT1 in ischemic preconditioning-induced cardioprotection. Methods Hearts isolated from SD male rats were subjected to either ischemia-reperfusion injury (I/R) (15 min global ischemia followed by 20 min reperfusion) or ischemic preconditioning (IPC) (3 cycles of 2 min global ischemia separated by 3 min reperfusion) followed by I/R in presence and absence of phlorizin, an SGLT1 inhibitor. Results IPC increased membrane SGLT1 expression in rat heart as observed by immunoblotting and immunohistochemistry. Hearts from I/R group showed significant increase in oxidative stress levels and marked myocardial injury as compared to control. We also observed significant increase in apoptotic parameters in I/R heart, as measured by caspase-3 activity, TUNEL positive nuclei and gene expression analysis. Significant improvement in oxidative stress, apoptosis parameters and cardiac injury was observed in I/R hearts when subjected to IPC. However, all beneficial effects of preconditioning were lost when hearts were pre-treated with phlorizin. Conclusion Present study indicated that inhibition of SGLT1 by phlorizin abrogated the beneficial effect of ischemic-preconditioning and for the first time, provides evidence that SGLT1 plays a crucial role in ischemic preconditioning-induced cardioprotection.

Original languageEnglish
Pages (from-to)392-398
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume472
Issue number2
DOIs
Publication statusPublished - 01-04-2016

Fingerprint

Ischemic Preconditioning
Reperfusion Injury
Heart Injuries
Phlorhizin
Oxidative stress
Rats
Oxidative Stress
Ischemia
Symporters
Facilitative Glucose Transport Proteins
In Situ Nick-End Labeling
Wounds and Injuries
Immunoblotting
Gene expression
Caspase 3
Reperfusion
Immunohistochemistry
Apoptosis
Membranes
Gene Expression

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Kanwal, Abhinav ; Nizami, Hina L. ; Mallapudi, Surekha ; Putcha, Uday Kumar ; Mohan, G. Krishna ; Banerjee, Sanjay K. / Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury. In: Biochemical and Biophysical Research Communications. 2016 ; Vol. 472, No. 2. pp. 392-398.
@article{19830f5632a041a6962069b08ed7172b,
title = "Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury",
abstract = "Background Recently, we reported Na+/glucose co-transporter (SGLT1) expression in mouse and human heart. We speculated that SGLT1 might play an important role in ischemic preconditioning-induced cardioprotection. Therefore, the present study was designed to find the role of SGLT1 in ischemic preconditioning-induced cardioprotection. Methods Hearts isolated from SD male rats were subjected to either ischemia-reperfusion injury (I/R) (15 min global ischemia followed by 20 min reperfusion) or ischemic preconditioning (IPC) (3 cycles of 2 min global ischemia separated by 3 min reperfusion) followed by I/R in presence and absence of phlorizin, an SGLT1 inhibitor. Results IPC increased membrane SGLT1 expression in rat heart as observed by immunoblotting and immunohistochemistry. Hearts from I/R group showed significant increase in oxidative stress levels and marked myocardial injury as compared to control. We also observed significant increase in apoptotic parameters in I/R heart, as measured by caspase-3 activity, TUNEL positive nuclei and gene expression analysis. Significant improvement in oxidative stress, apoptosis parameters and cardiac injury was observed in I/R hearts when subjected to IPC. However, all beneficial effects of preconditioning were lost when hearts were pre-treated with phlorizin. Conclusion Present study indicated that inhibition of SGLT1 by phlorizin abrogated the beneficial effect of ischemic-preconditioning and for the first time, provides evidence that SGLT1 plays a crucial role in ischemic preconditioning-induced cardioprotection.",
author = "Abhinav Kanwal and Nizami, {Hina L.} and Surekha Mallapudi and Putcha, {Uday Kumar} and Mohan, {G. Krishna} and Banerjee, {Sanjay K.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.bbrc.2016.02.016",
language = "English",
volume = "472",
pages = "392--398",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury. / Kanwal, Abhinav; Nizami, Hina L.; Mallapudi, Surekha; Putcha, Uday Kumar; Mohan, G. Krishna; Banerjee, Sanjay K.

In: Biochemical and Biophysical Research Communications, Vol. 472, No. 2, 01.04.2016, p. 392-398.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury

AU - Kanwal, Abhinav

AU - Nizami, Hina L.

AU - Mallapudi, Surekha

AU - Putcha, Uday Kumar

AU - Mohan, G. Krishna

AU - Banerjee, Sanjay K.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background Recently, we reported Na+/glucose co-transporter (SGLT1) expression in mouse and human heart. We speculated that SGLT1 might play an important role in ischemic preconditioning-induced cardioprotection. Therefore, the present study was designed to find the role of SGLT1 in ischemic preconditioning-induced cardioprotection. Methods Hearts isolated from SD male rats were subjected to either ischemia-reperfusion injury (I/R) (15 min global ischemia followed by 20 min reperfusion) or ischemic preconditioning (IPC) (3 cycles of 2 min global ischemia separated by 3 min reperfusion) followed by I/R in presence and absence of phlorizin, an SGLT1 inhibitor. Results IPC increased membrane SGLT1 expression in rat heart as observed by immunoblotting and immunohistochemistry. Hearts from I/R group showed significant increase in oxidative stress levels and marked myocardial injury as compared to control. We also observed significant increase in apoptotic parameters in I/R heart, as measured by caspase-3 activity, TUNEL positive nuclei and gene expression analysis. Significant improvement in oxidative stress, apoptosis parameters and cardiac injury was observed in I/R hearts when subjected to IPC. However, all beneficial effects of preconditioning were lost when hearts were pre-treated with phlorizin. Conclusion Present study indicated that inhibition of SGLT1 by phlorizin abrogated the beneficial effect of ischemic-preconditioning and for the first time, provides evidence that SGLT1 plays a crucial role in ischemic preconditioning-induced cardioprotection.

AB - Background Recently, we reported Na+/glucose co-transporter (SGLT1) expression in mouse and human heart. We speculated that SGLT1 might play an important role in ischemic preconditioning-induced cardioprotection. Therefore, the present study was designed to find the role of SGLT1 in ischemic preconditioning-induced cardioprotection. Methods Hearts isolated from SD male rats were subjected to either ischemia-reperfusion injury (I/R) (15 min global ischemia followed by 20 min reperfusion) or ischemic preconditioning (IPC) (3 cycles of 2 min global ischemia separated by 3 min reperfusion) followed by I/R in presence and absence of phlorizin, an SGLT1 inhibitor. Results IPC increased membrane SGLT1 expression in rat heart as observed by immunoblotting and immunohistochemistry. Hearts from I/R group showed significant increase in oxidative stress levels and marked myocardial injury as compared to control. We also observed significant increase in apoptotic parameters in I/R heart, as measured by caspase-3 activity, TUNEL positive nuclei and gene expression analysis. Significant improvement in oxidative stress, apoptosis parameters and cardiac injury was observed in I/R hearts when subjected to IPC. However, all beneficial effects of preconditioning were lost when hearts were pre-treated with phlorizin. Conclusion Present study indicated that inhibition of SGLT1 by phlorizin abrogated the beneficial effect of ischemic-preconditioning and for the first time, provides evidence that SGLT1 plays a crucial role in ischemic preconditioning-induced cardioprotection.

UR - http://www.scopus.com/inward/record.url?scp=84959885090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959885090&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2016.02.016

DO - 10.1016/j.bbrc.2016.02.016

M3 - Article

C2 - 26920054

AN - SCOPUS:84959885090

VL - 472

SP - 392

EP - 398

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -